Skip to main content
Log in

Abecarnil, a β-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Development of tolerance and dependence has been reported to occur upon chronic administration of traditional benzodiazepines (BZDs). We compared the effect of chronic treatment with abecarnil, a β-carboline derivative with high affinity for central BDZ receptors, and diazepam, the BDZ prototype, in mice.

After acute administration, abecarnil was as potent and effective as diazepam in protecting from bicuculline-induced convulsion. The time-course analysis of two peak equieffective doses of abecarnil (1.9 mg/kg p.o.) and diazepam (2.7 mg/kg p.o.) showed a similar duration of action. The anticonvulsant potency of diazepam was reduced in mice given chronic diazepam (25 mg/kg p.o., 2 times a day for 17 days). No tolerance to abecarnil was apparent when the drug was administered for the same period using a comparable dose (20 mg/kg p.o.). Severe symptoms of precipitated withdrawal were observed upon administration of the BDZ partial inverse agonist Ro 15-3505 in mice treated chronically with diazepam but not abecarnil. In mice made tolerant to diazepam, maximum [3H]-flumazenil binding sites were reduced in both cerebral cortex (−50%) and cerebellum (−55.2%). No changes in [3H]-flumazenil binding were measured in chronic abecarnil-treated mice.

These data indicate that abecarnil possesses a very low tolerance/dependence liability and does not affect BZD receptor density after chronic administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Auta J, Giusti P, Guidotti A, Costa E (1994) Imidazenil, a partial positive allosteric modulator of GABAA receptor, exhibits low tolerance and dependence liabilities in the rat. J Pharmacol Exp Ther 270: 1262–1269

    Google Scholar 

  • Ballenger JC, Mc Donald S, Noyes R, Rickels K, Sussman N, Woods S, Patin J, Singer J (1991) The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecamil (ZK 112–119) in generalized anxiety disorder. Phychopharmacol Bull 27: 171–179

    Google Scholar 

  • Feely M, Boyland P, Picardo A, Cox A, Gent JP (1989) Lack of anticonvulsant tolerance with RU 32698 and Ro 17–1812. Eur J Pharmacol 164: 377–380

    Google Scholar 

  • Finney DJ (1971) Probit analysis, 3rd Edition. Cambridge University Press, Cambridge, UK

    Google Scholar 

  • Gallager DW, Marley RJ, Hernandez TD (1991) Biochemical and electrophysiological mechanisms underlying benzodiazepine tolerance and dependence. In: Pratt J (ed) The biological bases of drug tolerance and dependence. Academic Press, London, pp 49–70

    Google Scholar 

  • Gobbi M, Barone D, Mennini T, Garattini S (1987). Diazepam and desmethyldiazepam differ in their affinity and efficacies at “central” and “peripheral” benzodiazepine receptors. J Pharm Pharmacol 39: 388–391

    Google Scholar 

  • Grimm WE, Hershkovitz M (1981) The effect of chronic diazepam treatment on discrimination performance and [3H]-flunitrazepam binding in the brains of shocked and nonshocked rats. Psychopharmacology 74: 132–136

    Google Scholar 

  • Haefely W, Martin JR, Schoch P. (1990) Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 11:452–456

    Google Scholar 

  • Haigh JRM, Feely M (1988). Tolerance to the anticonvulsant effect of benzodiazepines. Trends Pharmacol Sci 9: 361–365

    Google Scholar 

  • Knoflach F, Drescher U, Schemer L, Malherbe P, Möhler H (1993) Full and partial agonism displayed by benzodiazepine receptor ligands at different recombinant GABAA receptor subtypes. J Pharmacol Exp Ther 266: 385–391

    Google Scholar 

  • Krause W, Mengel H (1990) Pharmakokinetics of the anxiolytic β-carbolines derivative, abecarnil, in the mouse, the rat, the rabbit, the dog, the cynomologous monkey and the baboon. Studies on species differences. Drug Res 40: 522–529

    Google Scholar 

  • Löscher W, Hönach D (1992) Withdrawal precipitation by benzodiazepine receptor antagonists in dog chronically treated with diazepam or the novel anxiolytic and anticonvulsant β-carboline abecarnil. Naunyn-Schmiedeberg's Arch Pharmacol 345: 452–460

    Google Scholar 

  • Löscher W, Rundfeldt C (1990) Development of tolerance to clobazam in fully kindled rats: effects of intermittent flumazenil administration. Eur J Pharmacol 180: 255–271

    Google Scholar 

  • Löscher W, Schwark WS (1985) Development of tolerance to the anticonvulsant effect of diazepam in amygadala kindled rats. Exp Neurol 90: 373–384

    Google Scholar 

  • Löscher W, Hönach D, Scherkl R, Hashem A, Frey H-H (1990) Pharmacokinetics, anticonvulsant efficacy and adverse effects of the novel anxiolytic β-carboline abecarnil, a novel ligand for benzodiazepine receptors after acute and chronic administration in dogs. J Pharmacol Exp Ther 255: 541–548

    Google Scholar 

  • Löscher W, Rundfeldt C, Hönach D (1991) Tolerance to anticonvulsant effect of the partial benzodiazepine-receptor agonist abecarnil in kindled rats involves learning. Eur J Pharmacol 202: 303–310

    Google Scholar 

  • Martin JR, Pieri L, Bonetti EP, Schaffner R, Burkard WP, Cumin R, Haefely W (1988) Ro 16–6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiatry 21:360–369

    Google Scholar 

  • Miller LG, Greenblatt DJ, Barnhill JG, Shader RI (1988) Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased-aminobutyricA receptor function. J Pharmacol Exp Ther 246: 170–176

    Google Scholar 

  • Miller LG, Galpern WR, Greenblatt DJ, Lumpkin M, Shader RI (1990) Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alteration. J Pharmacol Exp Ther 254: 33–38

    Google Scholar 

  • Moreau J-L, Jenck F, Pieri L, Schoch P, Martin JR, Haefely W (1990) Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16–6028. Eur J Pharmacol 190: 269–273

    Google Scholar 

  • Pribilla I, Neuhaus R, Huba R, Hillmann M, Turner JD, Stephens DN, Schneider HH (1993) Abecamil is a full agonist at same, and a partial agonist at other recombinant GABAA receptor subtypes. In: Stephens DN (ed) Anxiolytic β-carbolines. From Molecolar Biology to the Clinic. Psychopharmacological Series 11. Springer, Heidelberg, pp 50–61

    Google Scholar 

  • Primus RJ, Gallager DW (1992) GABAA receptor subunit niRNA levels are differentially influenced by chronic FG 7142 and diazepan exposure. Eur J Pharmacol 226: 21–28

    Google Scholar 

  • Ritschel WA (1986) Handbook of basic pharmacokinetics. Drug Intelligence Publ, Hamilton, Ill, USA

    Google Scholar 

  • Rosenberg HC, Chin TH (1981) Tolerance during chronic benzodiazepine treatment is associated with decreased receptor binding. Eur J Pharmacol 70: 453–460

    Google Scholar 

  • Sacchi-Landriani G, Guardabasso V, Rocchetti M (1983) A microcomputer program for non-linear fitting. Comp Progr Biomed 16: 35–42

    Google Scholar 

  • Sannerud CA, Ator NA, Griffiths RR (1992) Behavioral pharmacology of abecamil in baboons: self-injection, drug discrimination and physical dependence. Behav Pharmacol 3: 507–516

    Google Scholar 

  • Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672

    Google Scholar 

  • Scherkl R, Scheuler W, Frey H-H (1985) Anticonvulsant effect of clonazepam in dog: development of tolerance and physical dependence. Arch Int Pharmacodyn Ther 278: 249–260

    Google Scholar 

  • Scherkl R, Schenler W, Frey H-H (1989) Clozepate in dogs: tolerance to the anticonvulsant effect and sign of physical dependence. Epilepsy Res 3: 144–150

    Google Scholar 

  • Schneider HH, Turski L, Krause W, Stephens DN (1990) Short-and long-tern tolerance to abecarnil, a beta-carboline benzodiazepine-receptor ligand: antagonism of PTZ convulsion threshold vs. receptor occupation and plasma level in the mouse. Soc Neurosci Abstr 16: 1037

    Google Scholar 

  • Serra M, Ghiani CA, Motzo C, Biggio G (1993) Pharmacological evidence for full agonist activity of abecarnil at certain GABAA receptors. In: Stephens DN (ed) Anxiolytic β-carbolines. From Molecular Biology to the Clinic. Psychopharmacological Series 11. Springer, Heidelberg, pp 62–78

    Google Scholar 

  • Stephens DN, Schneider HH, Kerh W, Andrews JS, Retting K-J, Turski L, Schmiechen R, Turner JD, Jensen LH, Petersen EN, Honoré T, Bondo Hansen, J (1990) Abecarnil, a metabolically stable, anxioselective β-carboline acting at benzodiazepine receptors. J Pharmacol Exp Ther 253: 334–343

    Google Scholar 

  • Stephens DN, Schneider HH, Turski L, Hillmann M, Huba R, Turner JD (1991) Abecamil: A β-carboline anxiolytic showing a selective action at central benzodiazepine receptors. Soc Neurosci Abstr 17: 1342

    Google Scholar 

  • Steppuhn KG, Schneider HH, Turski L, Stephens DN (1993) Longterm treatment with abecarnil does not induce diazepam-like dependence in mice. J Pharmacol Exp Ther 264: 1395–1400

    Google Scholar 

  • Tallman JF, Gallager, DW (1985) The GABAergic system: a locus of benzodiazepine action. Annu Rev Neurosci 8: 21–44

    Google Scholar 

  • Tietz EI, Rosenberg HC, Chin TH (1986) Autoradiografic localization of benzodiazepine receptor down-regulation. J Pharmacol Exp Ther 236: 284–292

    Google Scholar 

  • Turski L, Stephens DN, Jensen LH, Petersen EN, Meldrum BS, Patel S, Bondo Hansen J, Löscher W, Schneider HH, Schmiecben R (1990) Anticonvulsant action of the β-carboline abecarnil — Studies in rodents and baboon, Papio papio. J Pharmacol Exp Ther 253:344–352

    Google Scholar 

  • Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39: 251–419

    Google Scholar 

  • Zanotti A, Mariot R, Contarino A, Lipartiti M, Giusti P (1996) Lack of anfconvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats. Br J Pharmacol 117: 647–652

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Natolino, F., Zanotti, A., Contarino, A. et al. Abecarnil, a β-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice. Naunyn-Schmiedeberg's Arch Pharmacol 354, 612–617 (1996). https://doi.org/10.1007/BF00170836

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00170836

Key words

Navigation